Robert G. Posey

This paper develops hybrid nanoparticles with improved stability and redox activity for ovarian cancer treatment and imaging.

This paper develops ultrabright NIR-II nanoprobes using molecular and protein engineering for ex vivo bioimaging, showing improved brightness and stability over existing clinical dyes.

This paper develops tumor-mimicking phantom models to better assess NIR-I/II nanoparticles in surgical settings by replicating tumor microenvironment features and optical properties.